Duquesne Family Office LLC / BBIO
Duquesne Family Office LLC’s Bridgebio Pharma Inc Position
Does Duquesne Family Office LLC own Bridgebio Pharma Inc (BBIO)? Not currently — the last reported position was 438.1K shares worth $15M in Q1 2025; the fund’s latest 13F (Q1 2026) no longer reports it.
Position Value
$15M
Q1 2025
Shares
438.1K
% of Portfolio
+0.49%
Quarters Held
1
position exited
Position History BBIO
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2025 | 438.1K | $15M | +0.49% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Duquesne Family Office LLC’s full portfolio or all institutional holders of BBIO.